Solar ink maker Innovalight shines with $15M
Innovalight, a Sunnyvale, Calif. company that has developed solar ink (made of liquid-like solar cells) capable of being printed onto conducting surfaces to generate power, has brought in $15 million of an anticipated $20 million round of equity and rights, according to a filing with the SEC.
This brings the company’s total raised to $55 million, with backers including Arch Venture Partners, Apax Partners, Convexa Capital, Harris & Harris, Seven Rosen Funds, Leader Ventures and Silicon… Continue Reading
Innovalight pushes solar ink to record efficiency
Innovalight, maker of liquid-like silicon cells that convert sunlight into energy, announced that its product has achieved 18 percent efficiency, a record for so-called solar inks. Given that typical solar panels are 12 percent efficient on average, this is quite the achievement — especially considering all of the unique applications for solar cells that you can print straight onto silicon.
Verified by both the U.S. Department of Energy’s National Reneable Energy Laboratory (NREL) and Germany’s Fraunhofer… Continue Reading
Spray-on solar ink is coming soon — to paint on roofs and generate energy
[Update: We've clarified this story to make clear that Innovalight is not involved with this project]
Technology to turn light-absorbing materials into nano-size particles to make so-called solar ink that can be sprayed on to roofs to generate energy, is apparently only three to five years from becoming a reality.
At least, that’s according to Brian Korgel, an entrepreneur and chemical engineer at the University of Texas at Austin. Korgel tells LiveScience that his project, which has… Continue Reading
Crescendo captures $5M to accelerate delivery of web apps
Crescendo Networks, a company that claims to deliver web applications for enterprises faster and more efficiently, has raised $5 million in a fourth round of venture funding from Trilogy Equity Partners, Evergreen Venture Partners, Apax Partners, StageOne Ventures and Challenge Fund, reports PE Hub. Based in Menlo Park, Calif., it has raised more than $45 million to date and plans to use its recent financing to build out its sales organization.
Aerovance inhales $38M for asthma drugs
Aerovance, developer of asthma medications, just brought in $38 million in a post-recapitalized third round of funding to push its lead drug candidate through a second phase of clinical trials. The company has already received $20 million, with the option of claiming the remaining $18 million as necessary.
Based in Berkeley, Calif., the company has already seen its drug, Aerovant, through the first part of second-phase trials. The company will use the new money to complete… Continue Reading
Transera raises $17M for on-demand call center technology
Transera, provider of software that lets its clients set up cost-effective call centers with agents (in-house or outsourced) all over the world, announced that it brought in $17 million in a fourth round of funding from Accel Partners, Apax Partners, Lighthouse Capital Partners and Storm Ventures. The Sunnyvale, Calif.-based company says it will use the money to go after new customers, improve its service infrastructure and continue developing its products.
In particular, Transera’s software, called Seratel,… Continue Reading
Xanodyne newest pharm co. to cancel IPO
Xanodyne joins a growing number of biopharmaceutical and life science companies calling it quits on going public, at least for now. The Newport, Ky.-based firm withdrew its filing on Friday, citing poor market conditions — it had been waiting since November. Not that the company is really hurting. It’s raised about $232 million to date, and announced successful results in phase three trials of its lead drug candidate in August.
In the past, it has received… Continue Reading
Innovalight rakes in $5M for solar cell ink
Investors Leader Ventures and Silicon Valley Bank have shined on solar cell company Innovalight, providing $5 million in new financing toward the development of silicon solar modules so small they can be painted onto surfaces like ink.
The Sunnyvale, Calif. company uses liquid processing of silicon to produce nanosize solar prarticles that are not only more efficient than crystalline wafers, but also much cheaper to make than regular solar panels. It received $28 million last year… Continue Reading
Innovalight raises $28M for new ink-based solar cell
Innovalight, a Silicon Valley company that says it has come up with new solar cell with nano-particles of silicon, has raised a large $28 million round of capital and said it plans to open a 30,000 square foot manufacturing facility next year.Innovalight is still being very vague on the details of its technology, and it’s very late to the game. There are already more than a dozen other large companies and start-ups that are developing… Continue Reading
VoodooVox, offering in-call ads, raises $8.1M
VoodooVox, a New York start-up that provides advertising within phone calls, said it has raised $8.1 million in a fourth round of financing.It is led by Softbank Capital, and includes existing investors Apax Partners, Disney’s Steamboat Ventures, and Village Ventures, also participated in the round.
VoodooVox’s product is called “In-Call Media,” and it inserts ad-supported audio content into the calls of large companies, mainly within customer service calls and the like. The company says its technology… Continue Reading
Digital Fuel, a service level agreement co., raises $5M more
Digital Fuel, a San Mateo, Ca. company that sells software to businesses that helps them manage customer relationship commitments, has raised a $5 million fifth round of funding.
Investors include existing backers Apax Partners, Benchmark Capital, Israel Seed Partners and Sigma Partners, according to the company.
The company has raised about $40 million in funding since it launched in 2000
Aerovance, asthma treatment company, finishes raising $60M
Aerovance, a Berkeley, Calif biopharmaceutical company looking to find a partner for its asthma treatement, Aerovant, reached back to year-old news and announced it has finished raising $60 million in a third round of financing.
There is “substantial very, very strong interest” by pharmaceutical and biotech companies in the asthma treatment, the company told VentureWire (sub required), though no specifics were given.
Here is the company’s announcement of the funding last year.
The company’s drugs target severe… Continue Reading
Transera raises $10M for outsourced call-center
Transera Communications, a company that offers outsourcing services to large companies to help them handle calls for customer and technical support, has raised $10 million.
The third round of funding for the Cupertino, Calif. company was first reported today by VentureWire (sub required).
The company is backed by Accel Partners, Apax Partners and Storm Ventures. Transera, which has raised $30 million in total, joins a field filled with other competitors, such as LiveOps, which just raised $28… Continue Reading
NextWave Wireless acquires mobile WiFI network co., Go Networks — at a loss?
NextWave Wireless, of San Diego, has agreed to acquire GO Networks, a Mountain View, Calif. mobile WiFi network provider.
It apparently comes at a loss for Go Networks’ investors, suggesting how competitive the WiFi industry is. According to the company’s statement, the purchase includes an initial cash payment of $13.3 million, plus up to $25.7 million in possible earnouts. NextWave also will assume around $7.46 million in GO Networks obligations.
However, as noted by PE… Continue Reading
Solid, a database co., gets more funding — after eating through a solid $70M
Solid Information Technology, a Cupertino database company that has raised at least $70 million since its founding in 1997, said it has raised €4 million more in additional financing to help it deliver its open source database products to large companies.
The funding round was done by existing investors Apax Partners and CapMan.
The company says its solidDB outperforms Oracle’s InnoDB.
Drug maker Affymax to issue shares, despite doubling losses
Affymax, a Palo Alto biotech company that makes synthetic peptide-based drugs to treat kidney diseases and cancer, is planning an initial public offering it hope could bring it as much as $84 million.
Its lead product, Hematide, is in Phase 2 trials in patients with anemia due to chronic kidney disease. The drug is also being tested to treat anemia in patients undergoing chemotherapy for cancer. The company has said it expects to sell 3.5… Continue Reading
Apax Partners will shutter its Menlo Park operations –a trend?
Apax Partners is planning to close its Menlo Park office at year-end, in what could be the beginning of a notable trend.
It is rare that anyone closes an office and moves away from Silicon Valley, and this is just the latest sign that things are getting tough in venture capital, and that some players are giving up on it. Apax is a large player, with eight other offices around the globe. The news was reported… Continue Reading